Search
Prostate Cancer Surveillance, Treatment Disparities Among Urology Conference Talks
Prostate cancer treatment disparities and the timing of active surveillance are among the topics UCSF clinicians will discuss at AUA’s 2024 Annual Meeting in San Antonio, May 2 – May 6.Prostate Cancer Test Is Missing Early Disease in Transgender Women
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment, reports a new study led by UC San Francisco.150 Milestone: Robotic Procedure Changes Prostate Cancer Care
UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone.Adult Acquired Buried Penis: Improving Patient Outcomes
Adult-acquired buried penis (AABP) is a condition in which excess or abnormal surrounding soft tissue covers the penis, resulting in sexual and urinary dysfunction. While it’s associated with obesity, AABP does not typically subside with weight loss.What Matters Most to Patients Dealing With Stress Urinary Incontinence?
Many patients experience stress urinary incontinence (SUI) following surgical treatment for prostate cancer. To understand the impact of SUI on quality of life, a team of UCSF researchers interviewed and surveyed patients and published a series of studies.UCSF Health’s Eric Small, MD, Elected ASCO President for 2025-2026 Term
The American Society of Clinical Oncology (ASCO) has elected Eric J. Small, MD, FASCO, to serve as its president for the term beginning in June 2025.UCSF Health Performs 150th Robotic Focal HIFU Procedure
UCSF is West Coast leader for the innovative, minimally invasive treatment for prostate cancer patients.Novel Intraoperative Prostate Cancer Imaging Method Reveals Previously Undetectable Disease
UCSF researchers led the first-in-human study of a novel near-infrared fluorescence imaging agent that targets prostate-specific membrane antigen (PSMA).Transgender Women Benefit from Prostate Cancer Screenings
Transgender women keep their prostates after gender-affirming surgery, and as a result are still at risk for prostate cancer.Renowned Urologic Specialist to Lead UCSF Urology Program
Benjamin N. Breyer, MD, MAS, FACS, a renowned leader in urology and urological surgery, has been appointed chair of the UCSF Department of Urology.Personalizing Prostate Cancer Screening May Improve the Accuracy of Detection
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer.Patients With Detectable PSA After Radical Prostatectomy Have Good Long-Term Outcomes, UCSF Researchers Find
Patients with a detectable prostate-specific antigen (PSA) after radical prostatectomy (RP) may have excellent long-term outcomes, according to two retrospective studies conducted by UCSF researchers.Novel Metabolic Imaging Method Detects Prostate Cancer Aggressiveness
UCSF investigators have shown that adding an emerging metabolic imaging technique to MR–transrectal ultrasound fusion prostate biopsies makes it possible to detect the extent and aggressiveness of prostate cancer more accurately than ever.New Guidance for Reducing Medication-Related Dementia Risk in Patients With Overactive Bladder
This consensus paper is designed to update urologists and other healthcare providers who prescribe anticholinergics about the risks of these medications and help guide them on when to use anticholinergics and when it is appropriate to use alternatives.Focal High-Intensity Focused Ultrasound Ablation for Intermediate-Risk Prostate Cancer
The urologic surgical oncology team has performed an average of five focal HIFU procedures a month since the device was installed last year, offering patients a new minimally invasive treatment option.New Guidance for Ethical Urinary Incontinence Care for Older Adults
An International Continence Society working group led by UCSF urologist Anne M. Suskind, MD, MS, FACS, FPM-RS, recently published a white paper that provides an ethical framework for caring for older adults with urinary incontinence.Renal Cell Carcinoma Research Sheds New Light on Advanced Disease
In a recent study, UCSF researchers found that renal cell carcinoma (RCC)with venous tumor thrombus(VTT) does not always signify metastatic disease with poor prognosis. These findings provide insight into the development of advanced RCC and may help to better inform surveillance regimens and treatment decisions and, ultimately, improve clinical outcomes.UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”
Eric Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care® awards.Precision Prostate Cancer Treatment Reduces ADT-Related Dementia Risk
In a new study, UCSF researchers found that cumulative androgen deprivation therapy (ADT) exposure was associated with the onset of dementia in a nationwide longitudinal registry of men with prostate cancer.Newly Approved Prostate Cancer Scan Can Detect Cells that Have Spread to Lymph Nodes
A revolutionary new diagnostic method for prostate cancer can detect prostate cancer cells that have spread to lymph nodes both inside and outside the pelvis, according to the UC San Francisco and UCLA team whose earlier work led to the test’s FDA approval.Hemodialysis Significantly Decreased for Patient with Primary Hyperoxaluria Type 1 in UCSF Study of Nedosiran
Researchers at UC San Francisco reported successful compassionate use of nedosiran to dramatically reduce plasma oxalate levels in a patient with primary hyperoxaluria type 1 (PH1).UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.UCSF Offers Growing Options for Focal Therapy in Prostate Cancer
In its commitment to tailoring prostate cancer treatment to the needs of each patient, UC San Francisco’s Department of Urology uses focal therapy as an important option for men with clinically significant cancers that are located in one region of the prostate.UCSF Researchers Help Gain FDA Approval for Prostate Cancer Imaging Technique
Method is a ‘game changer’ that should become the standard of care, say UCSF researchers who validated its effectiveness.